Table 1. Comparison of clinical data between survival and death groups.
| Factors | Survival group (n=5) | Death group (n=18) | P value |
|---|---|---|---|
| Age | 45 [20–62] | 54 [48–61] | 0.279 |
| BMI | 20.9 (19.3–22.9) | 22.6 (20.3–23.7) | 0.297 |
| ECMO duration (h) | 146.0 (125.5–167.5) | 159.0 (142.5-205.3) | 0.331 |
| CRRT duration (h) | 134.0 (80.5–144.5) | 125.0 (111.3–206.5) | 0.412 |
| MV duration (days) | 9.0 (8.5–11.0) | 10.5 (9.0–14.3) | 0.259 |
| ICU length (days) | 12.0 (8.5–17.5) | 16.5 (13.0–19.3) | 0.124 |
| Hospital length (days) | 19.0 (17.5–21.0) | 16.5 (13.0–21.0) | 0.312 |
| ScvO2% at 24 h during ECMO | |||
| ECMO initiation | 1 (20.00%) | 2 (11.11%) | 0.602 |
| 6 h during ECMO | 2 (40.00%) | 4 (22.22%) | 0.259 |
| 12 h during ECMO | 4 (80.00%) | 4 (22.22%) | 0.033* |
| 18 h during ECMO | 5 (100.00%) | 7 (38.89%) | 0.016* |
| 24 h during ECMO | 5 (100.00%) | 9 (50.00%) | 0.043* |
| Shock-to-ECMO interval (h) | 23.5 (14.7–26.9) | 42.2 (24.3–80.9) | 0.037* |
| WBC | 12.9 (9.8–16.5) | 12.2 (10.4–14.0) | 0.801 |
| pH | 7.14 (6.96–7.32) | 7.17 (7.03–7.28) | 0.971 |
| Lac | 4.4 (2.2–7.4) | 6.8 (5.5–8.9) | 0.067 |
| SOFA | 12.0 (10.0–13.0) | 15.0 (13.0–18.3) | 0.007* |
| ALT | 123.0 (88.0–184.0) | 105.5 (88.5–124.8) | 0.446 |
| TBIL | 33.6 (29.5–42.0) | 35.5 (30.8–41.3) | 0.971 |
| Cr | 178.0 (102.5–223.5) | 173.0 (117.5–236.8) | 0.801 |
| PCT | 12.7 (12. 5–15.6) | 16.1 (14.4–17.4) | 0.199 |
| Hb | 98.0 (90.5–116.5) | 100.5 (85.8–105.3) | 0.638 |
| PT | 21.0 (16.5–27.5) | 21.5 (18.8–27.3) | 0.801 |
| APTT | 53.0 (46.5–60.0) | 55.5 (49.3–64.3) | 0.446 |
Values are median (25th to 75th percentile). *, P<0.05. BMI, body mass index; ECMO, extracorporeal membrane oxygenation; CRRT, continuous renal replacement therapy; MV, mechanical ventilation; ICU, intensive care unit; ScvO2, central venous oxygen saturation; WBC, white blood cell; SOFA, sepsis-related organ failure assessment; ALT, alanine aminotransferase; TBIL, total bilirubin; Cr, creatinine; PCT, procalcitonin; Hb, hemoglobin; PT, prothrombin time; APTT, activated partial thromboplastin time.